Search results for: Market Access
Filter search results
Review of Plans for Refining Patient-Reported Outcomes Measures
19 February 2013
…the EuroQol Group’s scientific research agenda for the coming year and plans for the EQ-5D-5L approach to measuring patient-reported outcomes of care. Health technology assessment affects patients’ access to oncology…
Understanding the Full Value of Long-Acting Therapies: less is more?
7 May 2025
…This will incentivise innovation, ensure equitable patient access, and support sustainable investments in transformative treatments for chronic disease management. Share this: Download publication These therapies are particularly effective for chronic…
OHE at ISPOR Europe 2: Conceptual and Practical Challenges in Judging Value
29 October 2014
…interpreting value. (PCN227, 12 Nov, 08:45–14:45) For a recent version of the study, click here. Dealing with uncertainty while enhancing access 4. Earlier Access to Innovation – Is It worth…
Inequalities in Dementia: Unveiling the Evidence and Forging a Path Towards Greater Understanding
26 June 2024
…dementia included those linking location, deprivation, socioeconomic status, age, culture, and ethnicity of people living with dementia with access to and experience of diagnosis and healthcare, A&E attendances and hospital…
OHE in the BMJ: Reforming the Cancer Drug Fund, and Reviving the PROMs Programme
10 December 2014
…for prioritising access to it “will continue to undermine NICE, duplicate effort, and distort allocation of NHS resources while failing to support the development of cost effective drugs from which…
Adult vaccination programmes deliver socio-economic benefits up to 19 times initial investment, according to new report
18 April 2024
…immunisation can deliver socio-economic returns proportional to childhood immunisation programmes (2). Despite this, access to adult vaccination is inconsistent around the world, with limited inclusion in routine immunisation schedules. Professor…
An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies
7 July 2015
…University of Singapore), OHE’s Mike Herdman and colleagues; a paper in Quality of life Research [open access] which assesses the performance of the EQ-VAS in the NHS, authored by…
New Publication: Risk-Sharing Agreements Between Pharmaceutical Manufacturers and Payers
25 September 2015
…entry agreements, patient access schemes, and coverage with evidence development (CED). The study involved a review of RSAs, alongside interviews and a survey, to explore key stakeholders’ experiences and expectations…
Multi-indication Pricing: Pros, Cons and Applicability to the UK
28 October 2015
…above suggests this may be achievable. On Tuesday 27 October, the Accelerated Access Review published their interim report. Their Proposition 2 (“Getting ahead of the curve”) reflects on the need…